EE9800037A - Sulfaamhappe derivaatide, atsüülsulfoonamiidide või sulfonüülkarbamaatide kasutamine lipoproteiini tasemeid vähendava ravimi valmistamiseks - Google Patents

Sulfaamhappe derivaatide, atsüülsulfoonamiidide või sulfonüülkarbamaatide kasutamine lipoproteiini tasemeid vähendava ravimi valmistamiseks

Info

Publication number
EE9800037A
EE9800037A EE9800037A EE9800037A EE9800037A EE 9800037 A EE9800037 A EE 9800037A EE 9800037 A EE9800037 A EE 9800037A EE 9800037 A EE9800037 A EE 9800037A EE 9800037 A EE9800037 A EE 9800037A
Authority
EE
Estonia
Prior art keywords
pct
sulphonylcarbamates
acylsulphonamides
medicament
manufacture
Prior art date
Application number
EE9800037A
Other languages
English (en)
Estonian (et)
Inventor
Robert Krause Brian
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of EE9800037A publication Critical patent/EE9800037A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EE9800037A 1995-08-04 1996-07-08 Sulfaamhappe derivaatide, atsüülsulfoonamiidide või sulfonüülkarbamaatide kasutamine lipoproteiini tasemeid vähendava ravimi valmistamiseks EE9800037A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US303195P 1995-08-04 1995-08-04
PCT/US1996/011366 WO1997005868A1 (en) 1995-08-04 1996-07-08 Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels

Publications (1)

Publication Number Publication Date
EE9800037A true EE9800037A (et) 1998-08-17

Family

ID=21703764

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800037A EE9800037A (et) 1995-08-04 1996-07-08 Sulfaamhappe derivaatide, atsüülsulfoonamiidide või sulfonüülkarbamaatide kasutamine lipoproteiini tasemeid vähendava ravimi valmistamiseks

Country Status (27)

Country Link
US (1) US6117909A (no)
EP (1) EP0841913B1 (no)
JP (1) JPH11510184A (no)
KR (1) KR19990036127A (no)
CN (1) CN1192140A (no)
AT (1) ATE232097T1 (no)
AU (1) AU716255B2 (no)
BG (1) BG63863B1 (no)
CA (1) CA2221729A1 (no)
CZ (1) CZ26198A3 (no)
DE (1) DE69626118T2 (no)
DK (1) DK0841913T3 (no)
EA (1) EA002435B1 (no)
EE (1) EE9800037A (no)
ES (1) ES2191762T3 (no)
GE (1) GEP20012511B (no)
HR (1) HRP960341A2 (no)
HU (1) HUP9900668A3 (no)
IL (1) IL122247A0 (no)
NO (1) NO980466D0 (no)
NZ (1) NZ312571A (no)
PL (1) PL185943B1 (no)
PT (1) PT841913E (no)
SK (1) SK12598A3 (no)
UA (1) UA46030C2 (no)
WO (1) WO1997005868A1 (no)
ZA (1) ZA966617B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1584333A3 (en) * 1998-01-28 2009-04-29 Warner-Lambert Company LLC Use of acetylcoenzime A inhibitors for treating Alzheimer's disease
JP2002521328A (ja) * 1998-07-21 2002-07-16 ワーナー−ランバート・カンパニー アテローム性動脈硬化症病変の治療のためのａｃａｔ阻害剤およびｍｍｐ阻害剤の併用投与
IT1303249B1 (it) * 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
AU1210401A (en) * 1999-11-05 2001-06-06 Warner-Lambert Company Prevention of plaque rupture by acat inhibitors
CA2369967A1 (en) * 2001-02-12 2002-08-12 Joseph Anthony Cornicelli Methods of treating nuclear factor-kappa b mediated diseases and disorders
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
US6939224B2 (en) * 2002-03-12 2005-09-06 Igt Gaming device having varying risk player selections
US11498904B2 (en) 2017-11-14 2022-11-15 Merck Sharp & Dohme Llc Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
TWI815829B (zh) 2017-11-14 2023-09-21 美商默沙東有限責任公司 作為吲哚胺2,3-二氧酶(ido)抑制劑之新穎經取代二芳基化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5003106A (en) * 1983-07-19 1991-03-26 American Cyanamid Company Antiatherosclerotic ureas and thioureas
ATE116291T1 (de) * 1990-10-30 1995-01-15 Warner Lambert Co Oxysulfonylcarbamate.
US5245068A (en) * 1990-10-30 1993-09-14 Warner-Lambert Company Oxysulfonyl carbamates
IL101785A0 (en) * 1991-05-10 1992-12-30 Fujisawa Pharmaceutical Co Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds

Also Published As

Publication number Publication date
EA002435B1 (ru) 2002-04-25
PL185943B1 (pl) 2003-09-30
DK0841913T3 (da) 2003-05-05
KR19990036127A (ko) 1999-05-25
HRP960341A2 (en) 1998-02-28
ATE232097T1 (de) 2003-02-15
ES2191762T3 (es) 2003-09-16
IL122247A0 (en) 1998-04-05
NO980466L (no) 1998-02-03
EP0841913A1 (en) 1998-05-20
GEP20012511B (en) 2001-08-27
NZ312571A (en) 2000-07-28
WO1997005868A1 (en) 1997-02-20
JPH11510184A (ja) 1999-09-07
BG63863B1 (bg) 2003-04-30
AU716255B2 (en) 2000-02-24
BG102222A (en) 1998-09-30
SK12598A3 (en) 1999-02-11
PT841913E (pt) 2003-06-30
CA2221729A1 (en) 1997-02-20
CZ26198A3 (cs) 1998-07-15
EA199800176A1 (ru) 1998-10-29
HUP9900668A3 (en) 2000-08-28
DE69626118D1 (de) 2003-03-13
ZA966617B (en) 1997-02-18
NO980466D0 (no) 1998-02-03
EP0841913B1 (en) 2003-02-05
UA46030C2 (uk) 2002-05-15
DE69626118T2 (de) 2003-11-27
CN1192140A (zh) 1998-09-02
AU6454196A (en) 1997-03-05
HUP9900668A2 (hu) 1999-06-28
PL324908A1 (en) 1998-06-22
US6117909A (en) 2000-09-12

Similar Documents

Publication Publication Date Title
ES2102195T3 (es) Derivados heterociclicos de acido carbonico que se fijan en receptores de retinoides.
YU32100A (sh) Derivati hidrosamske kiseline kao inhibitori matrične metaloproteaze (mmp)
CO5011115A1 (es) Compuestos y metodos quimioquina
ES2124545T3 (es) Azolidindionas como agentes antihiperglucemicos.
ES2177581T3 (es) Uso de compuestos de piperidina en el tratamiento de esquizofrenia.
PT638075E (pt) Inibidor da reaccao de maillard
EE9800037A (et) Sulfaamhappe derivaatide, atsüülsulfoonamiidide või sulfonüülkarbamaatide kasutamine lipoproteiini tasemeid vähendava ravimi valmistamiseks
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
FI970279A (fi) Orgaanisia yhdisteitä
DE69512208D1 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
MX9709275A (es) Uso de los derivados del acido sulfamico, carbamatos acil sulfonamidas o sulfonil para la manufactura de un medicamento para disminuir los niveles de lipoproteinas.
DE69421705D1 (de) Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen
DE69816832D1 (de) Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3-benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen
MX9201288A (es) Metodo de tratamiento.
SE9401965D0 (sv) New compounds
MXPA04000139A (es) Uso de compuestos biciclo para tratar enfermedad de alzheimer.